Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia

Cancer Research

Volumn 57, Issue 5, 1997, Pages 832-836

  Batova, Ayse ^a   Diccianni, Mitchell B ^a   Yu, John C ^c   Nobori, Tsutomu ^b   Link, Michael P ^d   Pullen, Jeanette ^e   Yu, Alice L ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI   (United States)

^f UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; DNA METHYLATION; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, T-CELL, ACUTE; RESTRICTION MAPPING; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 0031035406     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
2. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-B-induced cell cycle. Nature (Lond.), 371: 257-261, 1994.
3. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K. Tautigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
4. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
5. Jen, J., Harper, W., Bigner, S. H., Bigner, D. D., Papadopoulas, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
6. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85: 2321-2330, 1995.
7. INK4b gene deletions in primary leukemias. Blood, 86: 311-315, 1995.
8. ink4 gene inactivation in acute lymphoblastic leukemia. Blood, 85: 3431-3436, 1995.
9. INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res., 56: 5023-5032, 1996.
10. INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55: 5531-5535, 1995.
11. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracapoli, N. C. Germline p16 mutations in familial melanoma, Nat. Genet., 8: 15-21, 1994.
12. Borg, A., Johansson, U., Johannsson, O., Hakansson, S., Westerdahl, J., Masback, A., Olsson, H., and Ingvar, C. Novel germ line p 16 mutation in familial malignant melanoma in southern Sweden. Cancer Res., 56: 2497-2500, 1996.
13. Gruis, N. A., van der Velden, P. A., Sandkuiji, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., and Frants, R. R. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds, Nat. Genet., 10: 351-353, 1995.
14. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M., Singh, A. D., Shields, J. A., Shields., C. L., Croce, C. M., and Huebner, K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res., 54: 5269-5272, 1994.
15. Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, V., Tokino, K., van der Riet, P., Blaugrund, J. E., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC). 265: 415-417, 1994.
16. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
17. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P, J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
18. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornour, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
19. Otterson, G. A., Khleif, S. N., Chen, W., Coxon, A. B., and Kaye, F. J., CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene, 11: 1211-1216, 1995.
20. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
21. INK4B1. Cancer Res., 56: 722-727, 1996.
22. Batova, A., Diccianni, M. B., Nobori, T., Vu, T., Bridgeman, L., Yu, J., and Yu, A. L. Frequent deletions in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy, Blood, 88: 3083-3090, 1996.
23. Diccianni, M. B., Batova, A., Yu, J., Vu, T., Pullen, J., Amylon, M., Pollock, B., and Yu, A. L. Gene status and clinical significance of p15, p16 and p18 in T cell acute lymphoblastic leukemia. Leuk. Res., in press, 1997
24. Diccianni, M. B., Chau, L. S., Batova, A., Vu, T. Q., and Yu, A. L. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett., 104: 183-192, 1996.
25. Lois, A. F., Cooper, L. T., Geng, Y., Nobori, T., and Carson, D. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res., 55: 4010-4013, 1995.
26. INK4B) display frequent homozygous deletion in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038-4044, 1994.
27. INK4 expression is frequent in high grade gliomas. Cancer Res., 55: 1941-1945, 1995.